Yvonne Pak
About Yvonne Pak
Yvonne Pak serves as the Executive Director of DMPK at BridgeBio, bringing extensive experience in clinical pharmacology and drug metabolism. Her career includes significant roles at Pharmacyclics, AbbVie, and Portola Pharmaceuticals, with a strong academic background in microbiology and pharmaceutical sciences.
Current Role at BridgeBio
Yvonne Pak serves as the Executive Director of DMPK at BridgeBio, a position she has held since 2023. In this role, she oversees the development and implementation of drug metabolism and pharmacokinetics strategies. Her responsibilities include leading research initiatives and collaborating with cross-functional teams to advance drug development projects.
Previous Experience at BridgeBio
Prior to her current role, Yvonne Pak worked at BridgeBio as Senior Director of DMPK from 2021 to 2023. During her tenure, she contributed to the strategic direction of pharmacokinetics and drug metabolism research, enhancing the company's capabilities in drug development.
Career at AbbVie
Yvonne Pak has held multiple positions at AbbVie. She served as Associate Director of Clinical Pharmacokinetics for six months in 2019, followed by a role as Director of Clinical Pharmacology from 2020 to 2021. Her work focused on advancing clinical pharmacology strategies and supporting drug development processes.
Experience at Pharmacyclics
Yvonne Pak worked at Pharmacyclics, an AbbVie Company, in various capacities from 2012 to 2019. She started as Senior Manager of Clinical Pharmacology and later became Associate Director of Clinical Pharmacology. Her contributions during this period were significant in shaping the clinical pharmacology framework within the organization.
Educational Background
Yvonne Pak earned her Bachelor of Science in Microbiology from the University of Arizona, completing her studies from 1994 to 1998. She later pursued a Doctor of Philosophy in Pharmaceutical Sciences with a focus on Pharmacokinetics at the same institution, achieving her PhD from 1998 to 2004. This educational foundation has been instrumental in her career in pharmacology and drug development.